The global Non-Invasive Prenatal Testing market was valued at US$ 4884.4 million in 2023 and is anticipated to reach US$ 10060 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.

Non-Invasive Prenatal Testing Market

Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood

North American market for Non-Invasive Prenatal Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Non-Invasive Prenatal Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Non-Invasive Prenatal Testing in 0-12 Weeks is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Non-Invasive Prenatal Testing include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Prenatal Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Prenatal Testing.

Report Scope

The Non-Invasive Prenatal Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Invasive Prenatal Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Invasive Prenatal Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Invasive Prenatal Testing Market Report

Report Metric	Details
Report Name	Non-Invasive Prenatal Testing Market
Accounted market size in 2023	US$ 4884.4 million
Forecasted market size in 2030	US$ 10060 million
CAGR	10.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	High & Average Risk Low Risk
Segment by Application	0-12 Weeks 13-24 Weeks 25-36 Weeks
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, Berry Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Prenatal Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Invasive Prenatal Testing Market growing?

Ans: The Non-Invasive Prenatal Testing Market witnessing a CAGR of 10.7% during the forecast period 2024-2030.

What is the Non-Invasive Prenatal Testing Market size in 2030?

Ans: The Non-Invasive Prenatal Testing Market size in 2030 will be US$ 10060 million.

Who are the main players in the Non-Invasive Prenatal Testing Market report?

Ans: The main players in the Non-Invasive Prenatal Testing Market are Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, Berry Genomics

What are the Application segmentation covered in the Non-Invasive Prenatal Testing Market report?

Ans: The Applications covered in the Non-Invasive Prenatal Testing Market report are 0-12 Weeks, 13-24 Weeks, 25-36 Weeks

What are the Type segmentation covered in the Non-Invasive Prenatal Testing Market report?

Ans: The Types covered in the Non-Invasive Prenatal Testing Market report are High & Average Risk, Low Risk

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 High & Average Risk

1.2.3 Low Risk

1.3 Market by Application

1.3.1 Global Non-Invasive Prenatal Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 0-12 Weeks

1.3.3 13-24 Weeks

1.3.4 25-36 Weeks

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Invasive Prenatal Testing Market Perspective (2019-2030)

2.2 Non-Invasive Prenatal Testing Growth Trends by Region

2.2.1 Global Non-Invasive Prenatal Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-Invasive Prenatal Testing Historic Market Size by Region (2019-2024)

2.2.3 Non-Invasive Prenatal Testing Forecasted Market Size by Region (2025-2030)

2.3 Non-Invasive Prenatal Testing Market Dynamics

2.3.1 Non-Invasive Prenatal Testing Industry Trends

2.3.2 Non-Invasive Prenatal Testing Market Drivers

2.3.3 Non-Invasive Prenatal Testing Market Challenges

2.3.4 Non-Invasive Prenatal Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Invasive Prenatal Testing Players by Revenue

3.1.1 Global Top Non-Invasive Prenatal Testing Players by Revenue (2019-2024)

3.1.2 Global Non-Invasive Prenatal Testing Revenue Market Share by Players (2019-2024)

3.2 Global Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-Invasive Prenatal Testing Revenue

3.4 Global Non-Invasive Prenatal Testing Market Concentration Ratio

3.4.1 Global Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Testing Revenue in 2023

3.5 Non-Invasive Prenatal Testing Key Players Head office and Area Served

3.6 Key Players Non-Invasive Prenatal Testing Product Solution and Service

3.7 Date of Enter into Non-Invasive Prenatal Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Prenatal Testing Breakdown Data by Type

4.1 Global Non-Invasive Prenatal Testing Historic Market Size by Type (2019-2024)

4.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2025-2030)

5 Non-Invasive Prenatal Testing Breakdown Data by Application

5.1 Global Non-Invasive Prenatal Testing Historic Market Size by Application (2019-2024)

5.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-Invasive Prenatal Testing Market Size (2019-2030)

6.2 North America Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

6.4 North America Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Invasive Prenatal Testing Market Size (2019-2030)

7.2 Europe Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

7.4 Europe Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Invasive Prenatal Testing Market Size (2019-2030)

8.2 Asia-Pacific Non-Invasive Prenatal Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Invasive Prenatal Testing Market Size (2019-2030)

9.2 Latin America Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

9.4 Latin America Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Invasive Prenatal Testing Market Size (2019-2030)

10.2 Middle East & Africa Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sequenom

11.1.1 Sequenom Company Detail

11.1.2 Sequenom Business Overview

11.1.3 Sequenom Non-Invasive Prenatal Testing Introduction

11.1.4 Sequenom Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.1.5 Sequenom Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Non-Invasive Prenatal Testing Introduction

11.2.4 Roche Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.2.5 Roche Recent Development

11.3 Natera

11.3.1 Natera Company Detail

11.3.2 Natera Business Overview

11.3.3 Natera Non-Invasive Prenatal Testing Introduction

11.3.4 Natera Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.3.5 Natera Recent Development

11.4 LabCorp

11.4.1 LabCorp Company Detail

11.4.2 LabCorp Business Overview

11.4.3 LabCorp Non-Invasive Prenatal Testing Introduction

11.4.4 LabCorp Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.4.5 LabCorp Recent Development

11.5 BGI Genomics

11.5.1 BGI Genomics Company Detail

11.5.2 BGI Genomics Business Overview

11.5.3 BGI Genomics Non-Invasive Prenatal Testing Introduction

11.5.4 BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.5.5 BGI Genomics Recent Development

11.6 Quest Diagnostics

11.6.1 Quest Diagnostics Company Detail

11.6.2 Quest Diagnostics Business Overview

11.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Introduction

11.6.4 Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.6.5 Quest Diagnostics Recent Development

11.7 Illumina

11.7.1 Illumina Company Detail

11.7.2 Illumina Business Overview

11.7.3 Illumina Non-Invasive Prenatal Testing Introduction

11.7.4 Illumina Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.7.5 Illumina Recent Development

11.8 Berry Genomics

11.8.1 Berry Genomics Company Detail

11.8.2 Berry Genomics Business Overview

11.8.3 Berry Genomics Non-Invasive Prenatal Testing Introduction

11.8.4 Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2019-2024)

11.8.5 Berry Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of High & Average Risk

Table 3. Key Players of Low Risk

Table 4. Global Non-Invasive Prenatal Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Non-Invasive Prenatal Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Non-Invasive Prenatal Testing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Non-Invasive Prenatal Testing Market Share by Region (2019-2024)

Table 8. Global Non-Invasive Prenatal Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Non-Invasive Prenatal Testing Market Share by Region (2025-2030)

Table 10. Non-Invasive Prenatal Testing Market Trends

Table 11. Non-Invasive Prenatal Testing Market Drivers

Table 12. Non-Invasive Prenatal Testing Market Challenges

Table 13. Non-Invasive Prenatal Testing Market Restraints

Table 14. Global Non-Invasive Prenatal Testing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Non-Invasive Prenatal Testing Market Share by Players (2019-2024)

Table 16. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2023)

Table 17. Ranking of Global Top Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Non-Invasive Prenatal Testing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Non-Invasive Prenatal Testing Product Solution and Service

Table 21. Date of Enter into Non-Invasive Prenatal Testing Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-Invasive Prenatal Testing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2019-2024)

Table 25. Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2025-2030)

Table 27. Global Non-Invasive Prenatal Testing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2019-2024)

Table 29. Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2025-2030)

Table 31. North America Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Non-Invasive Prenatal Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Sequenom Company Detail

Table 47. Sequenom Business Overview

Table 48. Sequenom Non-Invasive Prenatal Testing Product

Table 49. Sequenom Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 50. Sequenom Recent Development

Table 51. Roche Company Detail

Table 52. Roche Business Overview

Table 53. Roche Non-Invasive Prenatal Testing Product

Table 54. Roche Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Natera Company Detail

Table 57. Natera Business Overview

Table 58. Natera Non-Invasive Prenatal Testing Product

Table 59. Natera Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 60. Natera Recent Development

Table 61. LabCorp Company Detail

Table 62. LabCorp Business Overview

Table 63. LabCorp Non-Invasive Prenatal Testing Product

Table 64. LabCorp Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 65. LabCorp Recent Development

Table 66. BGI Genomics Company Detail

Table 67. BGI Genomics Business Overview

Table 68. BGI Genomics Non-Invasive Prenatal Testing Product

Table 69. BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 70. BGI Genomics Recent Development

Table 71. Quest Diagnostics Company Detail

Table 72. Quest Diagnostics Business Overview

Table 73. Quest Diagnostics Non-Invasive Prenatal Testing Product

Table 74. Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 75. Quest Diagnostics Recent Development

Table 76. Illumina Company Detail

Table 77. Illumina Business Overview

Table 78. Illumina Non-Invasive Prenatal Testing Product

Table 79. Illumina Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 80. Illumina Recent Development

Table 81. Berry Genomics Company Detail

Table 82. Berry Genomics Business Overview

Table 83. Berry Genomics Non-Invasive Prenatal Testing Product

Table 84. Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 85. Berry Genomics Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-Invasive Prenatal Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Non-Invasive Prenatal Testing Market Share by Type: 2023 VS 2030

Figure 3. High & Average Risk Features

Figure 4. Low Risk Features

Figure 5. Global Non-Invasive Prenatal Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Non-Invasive Prenatal Testing Market Share by Application: 2023 VS 2030

Figure 7. 0-12 Weeks Case Studies

Figure 8. 13-24 Weeks Case Studies

Figure 9. 25-36 Weeks Case Studies

Figure 10. Non-Invasive Prenatal Testing Report Years Considered

Figure 11. Global Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Non-Invasive Prenatal Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Non-Invasive Prenatal Testing Market Share by Region: 2023 VS 2030

Figure 14. Global Non-Invasive Prenatal Testing Market Share by Players in 2023

Figure 15. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Testing Revenue in 2023

Figure 17. North America Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 19. United States Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 23. Germany Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Non-Invasive Prenatal Testing Market Share by Region (2019-2030)

Figure 31. China Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 39. Mexico Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 43. Turkey Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Sequenom Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 46. Roche Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 47. Natera Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 48. LabCorp Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 49. BGI Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 50. Quest Diagnostics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 51. Illumina Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 52. Berry Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2019-2024)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions